TLR‐MyD88 signaling blockades inhibit refractory B‐1b cell immune responses to transplant‐related glycan antigens-Reference-Cited by-同舟云学术

TLR‐MyD88 signaling blockades inhibit refractory B‐1b cell immune responses to transplant‐related glycan antigens

Published:2020-09-27 Issue:4 Volume:21 Page:1427-1439
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Sakai Hiroshi¹²,Tanaka Yuka¹,Tanaka Asuka¹,Ohdan Hideki¹^ORCID

Affiliation:

1. Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biochemical and Health Sciences Hiroshima University Hiroshima Japan

2. Department of Medicine Columbia Center for Translational Immunology Columbia University Medical Center New York NY USA

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16288

Reference54 articles.

1. A unique natural human IgG antibody with anti-alpha-galactosyl specificity.

2. Evidence that intravenously administered alpha‐galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts;Ye Y;Transplantation,1994

3. Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens

4. Multiple Regulatory Mechanisms Control B-1 B Cell Activation

5. MyD88- and Bruton’s Tyrosine Kinase-Mediated Signals Are Essential for T Cell-Independent Pathogen-Specific IgM Responses

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of a MyD88 inhibitor alleviates rejection and inflammation in xenotransplantation by inhibiting dendritic cells activation and trained immunity in macrophages;International Immunopharmacology;2024-03